CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 87  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0561
LYS 10.0110
GLU 20.0079
LEU 30.0127
ARG 40.0214
CYS 50.0092
GLN 60.0173
CYS 70.0128
ILE 80.0138
LYS 90.0048
THR 100.0174
TYR 110.0076
SER 120.0203
LYS 130.0160
PRO 140.0094
PHE 150.0278
HIS 160.0347
PRO 170.0159
LYS 180.0322
PHE 190.0135
ILE 200.0201
LYS 210.0292
GLU 220.0048
LEU 230.0219
ARG 240.0292
VAL 250.0136
ILE 260.0151
GLU 270.0265
SER 280.0156
GLY 290.0503
PRO 300.0186
HIS 310.0116
CYS 320.0226
ALA 330.0561
ASN 340.0100
THR 350.0251
GLU 360.0128
ILE 370.0151
ILE 380.0179
VAL 390.0104
LYS 400.0209
LEU 410.0267
SER 420.0349
ASP 430.0341
GLY 440.0262
ARG 450.0272
GLU 460.0288
LEU 470.0103
CYS 480.0095
LEU 490.0167
ASP 500.0165
PRO 510.0115
LYS 520.0390
GLU 530.0214
ASN 540.0323
TRP 550.0227
VAL 560.0234
GLN 570.0312
ARG 580.0215
VAL 590.0051
VAL 600.0163
GLU 610.0110
LYS 620.0137
PHE 630.0115
LEU 640.0154
LYS 650.0137
ARG 660.0208
ALA 670.0158
GLU 680.0357
ASN 690.0198

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.